DexCom Inc (DXCM)
Pretax margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 709,000 | 743,900 | 806,900 | 778,400 | 710,400 | 597,400 | 503,200 | 419,200 | 390,800 | 242,900 | 187,400 | 188,800 | 173,900 | 269,900 | 254,300 | 223,800 | 225,000 | 238,000 | 208,700 | 153,200 |
Revenue (ttm) | US$ in thousands | 4,033,000 | 3,954,000 | 3,934,800 | 3,801,800 | 3,622,300 | 3,403,000 | 3,197,600 | 3,022,500 | 2,909,800 | 2,792,800 | 2,673,400 | 2,572,300 | 2,448,500 | 2,319,200 | 2,169,900 | 2,026,600 | 1,926,700 | 1,820,600 | 1,716,000 | 1,600,600 |
Pretax margin | 17.58% | 18.81% | 20.51% | 20.47% | 19.61% | 17.56% | 15.74% | 13.87% | 13.43% | 8.70% | 7.01% | 7.34% | 7.10% | 11.64% | 11.72% | 11.04% | 11.68% | 13.07% | 12.16% | 9.57% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $709,000K ÷ $4,033,000K
= 17.58%
DexCom Inc's pretax margin has shown fluctuations over the period analyzed. It started at 9.57% on March 31, 2020, and generally trended upwards, reaching a peak of 20.51% on June 30, 2024. However, there were periods of decline, such as the decreases in pretax margin from December 31, 2021 (7.10%) to March 31, 2022 (7.34%) and from September 30, 2024 (18.81%) to December 31, 2024 (17.58%). Overall, DexCom Inc has shown improvement in its pretax margin performance, indicating effective management of costs and expenses relative to its pre-tax earnings over the period.
Peer comparison
Dec 31, 2024
Company name
Symbol
Pretax margin
DexCom Inc
DXCM
17.58%
3M Company
MMM
20.60%
Artivion Inc
AORT
-1.93%
Baxter International Inc
BAX
-4.61%
Becton Dickinson and Company
BDX
9.94%
Boston Scientific Corp
BSX
13.63%
Embecta Corp
EMBC
3.96%
Glaukos Corp
GKOS
-38.94%
Globus Medical
GMED
4.79%
Haemonetics Corporation
HAE
5.85%
ICU Medical Inc
ICUI
-3.47%